Subjects
- Compassionate Use Trials -- standards2
- Device Approval -- standards2
- Equipment and Supplies -- classification2
- Etanercept -- therapeutic use2
- Immunologic Factors -- economics2
- Infliximab -- therapeutic use2
- Insurance Coverage -- economics2
- Interleukin-6 -- antagonists & inhibitors2
- Medicaid -- economics2
- Rituximab -- therapeutic use2
- Abuse-Deterrent Formulations -- economics1
- Abuse-Deterrent Formulations -- statistics & numerical data1
- Adult1
- Amyloid Neuropathies, Familial -- drug therapy1
- Amyloidosis, Familial -- complications1
- Amyloidosis, Familial -- drug therapy1
- Analgesics -- adverse effects1
- Analgesics -- therapeutic use1
- Analgesics, Opioid -- economics1
- Androgen Antagonists -- adverse effects1